Skip to: Content
Skip to: Site Navigation
Skip to: Search

SUNDAY, NOVEMBER 22, 2009
| Subscribe to Newser's RSS feeds RSS | Follow Newser on Twitter Twitter

NEWS ABOUT: prostate-specific antigen

prostate-specific antigen stories: 4 news summaries

Virus Linked to Aggressive Prostate Cancer

Connection may lead to better diagnosis, customized treatment

(Newser) - Aggressive human prostate cancer cells contain a virus associated with cancer in animals, a discovery that raises hopes for more accurate diagnosis and treatment of the disease, the Salt Lake Tribune reports. "We're not saying this virus causes cancer," cautioned the lead researcher. "The best we can... More »

MORE ABOUT:
cancer prostate cancer Columbia University prostate specific antigen University of Utah prostate-specific antigen PSA test XMRV

OPINION

Don't Be Fooled: Prostate Cancer Screening Is Key

Guidelines against
PSA testing
could cost lives

(Newser) - A national task force’s recent warning against prostate cancer screenings in some men could put their lives at risk, cautions physician and researcher William J. Catalona in the Washington Post. “It's important to note that consideration was not given to the overwhelming body of emerging evidence that screening... More »

MORE ABOUT:
prostate cancer American Cancer Society cancer screening PSA American Urological Association prostate-specific antigen

 Panel: Don't Screen
 Older Men for
 Prostate Cancer

Treatment may be more harmful than helpful after the age of 74

(Newser) - Physicians should stop screening men 75 and older for prostate cancer, according to new guidelines issued by national health task force. Prostate cancer is "overdiagnosed" in up to 44% of cases—that is, the cancer is present but so slow growing that it would probably never produce symptoms in... More »

 Pill Delivers
 Prostate Cancer
 Breakthrough 

Daily pill shrinks advanced tumors

(Newser) - A new experimental pill taken once a day is proving effective against an advanced, aggressive form of prostate cancer which has resisted other therapies, reports Reuters. The drug, abiraterone, created by Cougar Biotechnology, significantly shrank tumors in a clinical trial, according to a study in the Journal of Clinical ... More »

MORE ABOUT:
prostate cancer Institute of Cancer Research PSA Cougar Biotechnology abiraterone CYP17 prostate-specific antigen

4 Stories